News | February 22, 2023
Genomics, big data among key themes driving M&A activity in medical devices, says GlobalData
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
Agasta Software is engaged in research, development and commercialization of medical devices
Canagliflozin and Metformin Hydrochloride Tablets had annual sales of US $49.4 million in the United States
There is a fast resurgence in the transplant activities post COVID
Sirolimus Tablets had annual sales of USD 69 million in the United States (IQVIA MAT Dec. 2022)
The EIR was issued post the last inspection of the facility conducted from October 17, 2022 to October 29, 2022
According to IQVIA sales data for the 12-month period ending December 2022, the Onglyza Tablets, 2.5 mg and 5 mg market achieved annual sales of approximately US $122.3 million
Bosentan Tablets for Oral Suspension had annual sales of USD 16 mn in the United States (IQVIA MAT Dec. 2022)
Subscribe To Our Newsletter & Stay Updated
